NEW YORK, December 19, 2025--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates ("Broadwood" or "we"), which together own 30.2% of the outstanding common stock of STAAR Surgical Company ...
Staar Surgical, a manufacturer of the Implantable Collamer Lens, has delayed a shareholder vote on Alcon’s planned $1.6 billion takeover offer for the fourth time since October. In October, the vote ...
LAKE FOREST, Calif., December 15, 2025--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA) ("STAAR"), the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses (EVO ...
STAAR Surgical (STAA) rose 4.4% in after-hours trading after proxy adviser ISS recommended that shareholders vote to approve Alcon's revised $30.75 a share offer. The ISS news comes after rival proxy ...
Investing.com -- The protracted, $1.6 billion dollar saga over STAAR Surgical Company (NASDAQ:STAA) is entering its final, chaotic phase with the acquisition by Alcon AG (NYSE:ALC) now hinged on a ...
Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which together own 30.2% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today ...
While STAAR’s stock rose 4.6% on Friday, up 4.2% on the week, a significant gap remains. With the stock still trading more than $5.50 below the $30.75 offer price, arbitrage traders are signaling a ...
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses (EVO ICL™) for vision correction, ...
STAAR Surgical (STAA) rose 4.4% in after-hours trading after proxy adviser ISS recommended that shareholders vote to approve Alcon's revised $30.75 a share offer. ISS recommended a vote for Alcon and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback